184 related articles for article (PubMed ID: 30390560)
1. Determination of tyrosine kinase inhibitor afatinib in rat plasma using LC-MS/MS and its application to in vivo pharmacokinetic studies of afatinib liposomes.
Lu X; Liu S; Yang X; Han M; Sun K
J Pharm Biomed Anal; 2019 Feb; 164():181-186. PubMed ID: 30390560
[TBL] [Abstract][Full Text] [Related]
2. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients.
Reis R; Labat L; Allard M; Boudou-Rouquette P; Chapron J; Bellesoeur A; Thomas-Schoemann A; Arrondeau J; Giraud F; Alexandre J; Vidal M; Goldwasser F; Blanchet B
J Pharm Biomed Anal; 2018 Sep; 158():174-183. PubMed ID: 29883880
[TBL] [Abstract][Full Text] [Related]
4. Novel Bruton tyrosine kinase inhibitor acalabrutinib quantification by validated LC-MS/MS method: An application to pharmacokinetic study in Sprague Dawley rats.
Surendran S; Paul D; Pokharkar S; Choulwar S; Deshpande A; Giri S; Satheeshkumar N
J Pharm Biomed Anal; 2019 Feb; 164():509-513. PubMed ID: 30453157
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
[TBL] [Abstract][Full Text] [Related]
6. A rapid and sensitive UPLC-MS/MS method for determination of HZ08 in rat plasma and tissues: application to a pharmacokinetic study of liposome injections.
Yan F; Sun M; Hang T; Sun J; Zhou X; Deng X; Ge L; Qian H; Ya D; Huang W
J Pharm Biomed Anal; 2015 Jan; 102():246-52. PubMed ID: 25305722
[TBL] [Abstract][Full Text] [Related]
7. Validated LC-MS/MS method for the determination of amlodipine enantiomers in rat plasma and its application to a stereoselective pharmacokinetic study.
Wang L; Liu W; Zhang Z; Tian Y
J Pharm Biomed Anal; 2018 Sep; 158():74-81. PubMed ID: 29860181
[TBL] [Abstract][Full Text] [Related]
8. Determination of kaurenoic acid in rat plasma using UPLC-MS/MS and its application to a pharmacokinetic study.
Jiang X; Shen Y; Wang H; Wang C; Ye X; Xiang Z
J Pharm Biomed Anal; 2019 Feb; 164():27-31. PubMed ID: 30339948
[TBL] [Abstract][Full Text] [Related]
9. Determination of fucoxanthinol in rat plasma by liquid chromatography-tandem mass spectrometry.
Zhang Y; Lin J; Yan G; Jin W; Chen W; Sun J; Yang L; Huang M; Hong Z
J Pharm Biomed Anal; 2019 Feb; 164():155-163. PubMed ID: 30390557
[TBL] [Abstract][Full Text] [Related]
10. Determination of teniposide in rat plasma by ultra performance liquid chromatography electrospray ionization tandem mass spectrometry after intravenous administration.
Wang J; Zhang Y; Guan T; Lin X; Tang X; Xu H
Biomed Chromatogr; 2009 Sep; 23(9):999-1006. PubMed ID: 19382244
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS method for the determination of the prodrug aripiprazole lauroxil and its three metabolites in plasma and its application to in vitro biotransformation and animal pharmacokinetic studies.
Sun Y; Lu X; Gai Y; Sha C; Leng G; Yang X; Liu W
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():67-75. PubMed ID: 29510329
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography-tandem mass spectrometry of recombinant human extracellular superoxide dismutase (rhSOD3) in mouse plasma and its application to pharmacokinetic study.
Jeong JW; Oh JH; Ji YG; Shin YM; Lee MH; Kang NS; Lee W; Kim SS; Kim TY; Koo TS
J Pharm Biomed Anal; 2019 Feb; 164():590-597. PubMed ID: 30469108
[TBL] [Abstract][Full Text] [Related]
14. A highly efficient and sensitive LC-MS/MS method for the determination of afatinib in human plasma: application to a metabolic stability study.
Kadi AA; Abdelhameed AS; Darwish HW; Attwa MW; Al-Shakliah NS
Biomed Chromatogr; 2016 Aug; 30(8):1248-55. PubMed ID: 26683307
[TBL] [Abstract][Full Text] [Related]
15. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
[TBL] [Abstract][Full Text] [Related]
16. Determination of Puquitinib in Human Plasma by HPLC-ESI MS/MS: Application to Pharmacokinetic Study.
Zhan J; Ding Y; Zou B; Liao H; Jiang W; Li S
Eur J Drug Metab Pharmacokinet; 2018 Oct; 43(5):555-564. PubMed ID: 29520719
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a LC-ESI-MS/MS method for the determination of swertiamarin in rat plasma and its application in pharmacokinetics.
Li HL; Peng XJ; He JC; Feng EF; Xu GL; Rao GX
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1653-8. PubMed ID: 21531636
[TBL] [Abstract][Full Text] [Related]
18. A novel UPLC-MS/MS method for sensitive quantitation of boldine in plasma, a potential anti-inflammatory agent: application to a pharmacokinetic study in rats.
Zeng RJ; Li Y; Chen JZ; Chou GX; Gao Y; Shao JW; Jia L; Wu SD; Wu SS
Biomed Chromatogr; 2015 Mar; 29(3):459-64. PubMed ID: 25065486
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
[TBL] [Abstract][Full Text] [Related]
20. An LC/MS quantitative and microdialysis method for cyclovirobuxine D pharmacokinetics in rat plasma and brain: The pharmacokinetic comparison of three different drug delivery routes.
Wei JB; Lai Q; Shumyak SP; Xu LF; Zhang CX; Ling JJ; Yu Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():185-93. PubMed ID: 26342162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
